Last Updated: November 13, 2026

PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE Drug Patent Profile

Name: PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Pseudoephedrine Hydrochloride And Chlorpheniramine Maleate, and when can generic versions of Pseudoephedrine Hydrochloride And Chlorpheniramine Maleate launch?

Pseudoephedrine Hydrochloride And Chlorpheniramine Maleate is a drug marketed by Cent Pharms, Graham Dm, and Kv Pharm. and is included in four NDAs.

The generic ingredient in PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate; pseudoephedrine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the chlorpheniramine maleate; pseudoephedrine hydrochloride profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE?
What are the global sales for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE?
What is Average Wholesale Price for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE?

Summary for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE

US Patents:	0
Applicants:	3
NDAs:	4
Clinical Trials:	2
Patent Applications:	1
DailyMed Link:	PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE at DailyMed

Drug patent expirations by year for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE

Recent Clinical Trials for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Sino-American Tianjin Smith Kline & French Laboratories Ltd	Phase 4
GlaxoSmithKline	Phase 4
Magna Pharmaceuticals, Inc.	Phase 3

See all PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE clinical trials

US Patents and Regulatory Information for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cent Pharms	PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate; pseudoephedrine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	019428-001	Aug 2, 1988		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Kv Pharm	PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate; pseudoephedrine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	071455-001	Mar 1, 1989		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Graham Dm	PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate; pseudoephedrine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	018844-001	Mar 20, 1985		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.